{"company":{"id":2285234,"name":"Replimune","domain":"replimune.com","url":"https://alion.io/company/replimune"},"section":"news","answer":"Replimune: 9 headlines on record, 5 headlines in the last 90 days. Its story counts 1 milestone.","figures":[{"label":"Headlines","value":"9"},{"label":"In 90 days","value":"5"},{"label":"Milestones","value":"1"}],"blocks":[{"key":"news","title":"Headlines","source":"the outlets named on each headline, each story once","rows":9},{"key":"story","title":"Milestones","source":"Each milestone is dated by its source: registers, filings, the press","rows":1}],"news":[{"date":"2026-09-28","kind":"News","title":"Stocks FinancialContent","source":"financialcontent.com","url":"https://financialcontent.com/stocks"},{"date":"2026-09-24","kind":"News","title":"Replimune stock falls 3.79 percent as losses persist","source":"Replimune stock falls 3.79 percent as losses persist","url":"https://ad-hoc-news.de/boerse/news/nebenwerte/replimune-stock-falls-3-79-percent-as-losses-persist/70173629"},{"date":"2026-09-23","kind":"News","title":"Replimune stock gains as share authorization doubles","source":"Replimune stock gains as share authorization doubles","url":"https://ad-hoc-news.de/boerse/news/nebenwerte/replimune-stock-gains-as-share-authorization-doubles/70163555"},{"date":"2026-09-21","kind":"News","title":"Citing Replimune approval, experts say localized cancer meds could redefine care","source":"BioSpace","url":"https://biospace.com/drug-development/citing-replimune-approval-experts-say-localized-cancer-meds-could-redefine-care"},{"date":"2026-09-03","kind":"News","title":"Replimune to Present at the Cantor Global Healthcare Conference 2026","source":"markets.businessinsider.com","url":"https://markets.businessinsider.com/news/stocks/replimune-to-present-at-the-cantor-global-healthcare-conference-2026-1036519224"},{"date":"2026-08-04","kind":"News","title":"Replimune's Melanoma FDA Decision Pending: This Analyst Sees 40% Upside, 'High Conviction' For Approval","source":"YahooFinance","url":"https://finance.yahoo.com/healthcare/articles/replimune-melanoma-fda-decision-pending-104437557.html"},{"date":"2026-05-30","kind":"News","title":"Replimune's Drug Got Third Chance After White House Intervention","source":"wsj.com","url":"https://wsj.com/health/pharma/how-replimunes-drug-got-third-chance-after-white-house-intervention-89453a87"},{"date":"2026-05-29","kind":"News","title":"Pharmalittle: We're reading about Replimune drug getting third try at FDA approval, a Pfizer deal in China, and more","source":"STAT","url":"https://statnews.com/pharmalot/2026/05/29/pharmalittle-were-reading-about-replimune-drug-getting-third-try-at-fda-approval-a-pfizer-deal-in-china-and-more/"},{"date":"2025-08-14","kind":"News","title":"Drug Approvals Hit an FDA Wall","source":"wsj.com","url":"https://wsj.com/opinion/fda-drug-approvals-marty-makary-vinay-prasad-stealth-biotherapeutics-replimune-21e99561"}],"story":[{"title":"Founded"}],"as_of":"2026-11-15","cite":"Replimune, News. Alion, Nov 15, 2026. https://alion.io/company/replimune/news","html_url":"https://alion.io/company/replimune/news","json_url":"https://alion.io/company/replimune/news.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","generated_at":"2026-11-15T18:48:50Z"}}